Target Audience:

This activity has been designed to meet the educational needs of APP's involved in the care of patients with rheumatic disease.

Program Overview

RhAPP's mission is to deliver comprehensive educational updates via a platform designed to allow for a rich interaction and exchange of ideas between APPs on the most clinically relevant topics in the treatment of immune-mediated inflammatory diseases. In addition, RhAPP will provide programming and opportunities designed to support peer-to-peer networking, career development and advancement for existing APPs and clinical placement for APPs joining the rheumatology workforce.

Educational Objectives:

After completing this activity, the participant should be better able to:

• Describe the latest clinical guidelines and treatment recommendations for the management of rheumatic disease
• Individualized treatment and dosing for patients with rheumatic disease by assessing the latest evidence-based benefits of the available treatments
• Assess the risk factors associated with each treatment recommendation and carefully monitor patients for adverse events
• Evaluate new treatment options for rheumatic disease and therapeutics development
• Assess the risk-benefit for patients receiving new therapeutics for rheumatic disease